Benzyl N-[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3-yl)-2-methylphenyl]carbamate

CAY10499 is a carbamate ester compound that functions as a monoglyceride lipase inhibitor. It is primarily used as a research reagent for studying the endocannabinoid system and related lipid signaling pathways.